Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Anaptysbio Inc (ANAB)

Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update GlobeNewswire - Tue May 12, 3:15PM CDT

Completed spin-off of First Tracks Biotherapeutics, Inc., its former biopharma operations business Now exclusively manages the financial collaborations for Jemperli with GSK and imsidolimab with Vanda...

ANAB : 57.77 (-3.25%)
Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors GlobeNewswire - Mon May 11, 8:15AM CDT

Strengthens Leadership Team and Board with additional business development, finance and royalty management expertise SAN DIEGO, May 11, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a...

ANAB : 57.77 (-3.25%)
AnaptysBio's Royalty Stream Prints Cash but the Pipeline Still Burns It Barchart - Sun May 10, 4:00PM CDT

Barchart Research What to Expect from ANAB Earnings ANAB Generated May 8, 2026 Current Price $69.33 EPS Estimate $$-0.31 Consensus Rating Strong Buy Average Move 7.09% AnaptysBio's Royalty Stream Prints...

ANAB : 57.77 (-3.25%)
AnaptysBio's Royalty Stream Prints Cash but the Pipeline Still Burns It Barchart - Sat May 9, 4:00PM CDT

Barchart Research What to Expect from ANAB Earnings ANAB Generated May 8, 2026 Current Price $69.33 EPS Estimate $$-0.31 Consensus Rating Strong Buy Average Move 7.09% AnaptysBio's Royalty Stream Prints...

ANAB : 57.77 (-3.25%)
AnaptysBio's Royalty Stream Prints Cash but the Pipeline Still Burns It Barchart - Fri May 8, 4:01PM CDT

Barchart Research What to Expect from ANAB Earnings ANAB Generated May 8, 2026 Current Price $69.33 EPS Estimate $$-0.31 Consensus Rating Strong Buy Average Move 7.09% AnaptysBio's Royalty Stream Prints...

ANAB : 57.77 (-3.25%)
Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference GlobeNewswire - Mon May 4, 3:15PM CDT

SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for  Jemperli with GSK and imsidolimab with Vanda, today announced...

ANAB : 57.77 (-3.25%)
AnaptysBio's Royalty Cash Machine Looks Bulletproof but the Pipeline Spin-Off Creates New Questions Barchart - Sun May 3, 4:00PM CDT

Barchart Research What to Expect from ANAB Earnings ANAB Generated May 1, 2026 Current Price $66.76 EPS Estimate $$-1.04 Consensus Rating Strong Buy Average Move 7.09% AnaptysBio's Royalty Cash Machine...

ANAB : 57.77 (-3.25%)
AnaptysBio's Royalty Cash Machine Looks Bulletproof but the Pipeline Spin-Off Creates New Questions Barchart - Sat May 2, 4:00PM CDT

Barchart Research What to Expect from ANAB Earnings ANAB Generated May 1, 2026 Current Price $66.76 EPS Estimate $$-1.04 Consensus Rating Strong Buy Average Move 7.09% AnaptysBio's Royalty Cash Machine...

ANAB : 57.77 (-3.25%)
AnaptysBio's Royalty Cash Machine Looks Bulletproof but the Pipeline Spin-Off Creates New Questions Barchart - Fri May 1, 4:02PM CDT

Barchart Research What to Expect from ANAB Earnings ANAB Generated May 1, 2026 Current Price $66.76 EPS Estimate $$-1.04 Consensus Rating Strong Buy Average Move 7.09% AnaptysBio's Royalty Cash Machine...

ANAB : 57.77 (-3.25%)
Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence PR Newswire - Tue Apr 28, 6:12PM CDT

WASHINGTON , April 28, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of the original research article titled "Efficacy and Safety of Imsidolimab...

ANAB : 57.77 (-3.25%)
VNDA : 6.22 (+0.48%)

Barchart Exclusives

3 Dividend Stocks Yielding Above 5% to Scoop Up Now Barchart - Tue May 26, 6:30PM CDT
These three dividend stocks combine strong yields with resilient businesses. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.